ストックスクリーナーアプリを入手
64.92
0.87%
-0.57
前日終値:
$65.49
開ける：
$66.21
24時間の取引高:
1.94M
Relative Volume:
1.79
時価総額：
$10.26B
収益：
$1.17B
当期純損益:
$150.71M
株価収益率:
69.06
EPS:
0.94
ネットキャッシュフロー:
$245.03M
1週間 パフォーマンス:
-1.55%
1か月 パフォーマンス:
-17.56%
6か月 パフォーマンス:
-10.64%
1年 パフォーマンス:
-9.48%
1日の値動き範囲:
$64.58
$66.87
1週間の範囲:
$63.51
$67.19
52週間の値動き範囲:
$61.16
$85.57
Bio Techne Corp Stock (TECH) Company Profile
TECH を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TECH
Bio Techne Corp
|
64.92 | 10.26B | 1.17B | 150.71M | 245.03M | 0.94 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.24 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
700.33 | 76.56B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
644.48 | 39.16B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
250.59 | 32.44B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
120.01 | 28.77B | 3.30B | -501.07M | 1.03B | -2.1146 |
Bio Techne Corp Stock (TECH) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-02-19 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2024-05-22 | ダウングレード | Citigroup | Buy → Neutral |
| 2024-02-08 | 開始されました | Scotiabank | Sector Outperform |
| 2024-02-02 | ダウングレード | Stifel | Buy → Hold |
| 2023-12-07 | 開始されました | UBS | Buy |
| 2023-08-28 | 開始されました | William Blair | Outperform |
| 2023-01-10 | アップグレード | Wells Fargo | Underweight → Equal Weight |
| 2022-12-14 | 開始されました | Deutsche Bank | Buy |
| 2022-12-12 | アップグレード | Citigroup | Neutral → Buy |
| 2022-12-07 | 開始されました | RBC Capital Mkts | Sector Perform |
| 2022-08-25 | 開始されました | Credit Suisse | Outperform |
| 2022-04-25 | ダウングレード | Wells Fargo | Equal Weight → Underweight |
| 2021-09-15 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-08 | アップグレード | Stephens | Equal-Weight → Overweight |
| 2021-02-23 | アップグレード | Stifel | Hold → Buy |
| 2021-01-25 | 繰り返されました | The Benchmark Company | Buy |
| 2020-11-10 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | 開始されました | Atlantic Equities | Overweight |
| 2020-07-15 | ダウングレード | Stephens | Overweight → Equal-Weight |
| 2020-05-27 | ダウングレード | Stifel | Buy → Hold |
| 2020-05-14 | 開始されました | The Benchmark Company | Buy |
| 2020-01-08 | 再開されました | Stephens | Overweight |
| 2020-01-08 | 開始されました | Wells Fargo | Equal Weight |
| 2020-01-07 | 開始されました | Citigroup | Neutral |
| 2019-11-15 | 開始されました | Stifel | Buy |
| 2019-07-02 | アップグレード | Janney | Neutral → Buy |
| 2019-01-14 | アップグレード | Stephens | Equal-Weight → Overweight |
| 2018-10-31 | ダウングレード | Craig Hallum | Buy → Hold |
| 2018-10-17 | 開始されました | Goldman | Neutral |
| 2018-06-15 | 開始されました | Argus | Buy |
| 2017-07-13 | 開始されました | Wells Fargo | Market Perform |
| 2017-02-09 | 開始されました | Citigroup | Buy |
| 2017-01-18 | 開始されました | Deutsche Bank | Buy |
| 2016-11-10 | 再開されました | Leerink Partners | Outperform |
| 2015-01-21 | 繰り返されました | Robert W. Baird | Outperform |
| 2013-09-20 | アップグレード | Robert W. Baird | Neutral → Outperform |
すべてを表示
Bio Techne Corp (TECH) 最新ニュース
Bio-Techne Expands RNAscope Probes For Human And Mouse Transcriptome In Spatial Biology - Nasdaq
Bio-Techne Launches Expanded Menu of RNAscope Probes for Human and Mouse Transcriptome to Advance Spatial Biology - Quantisnow
Deep Dive Into Bio-Techne Stock: Analyst Perspectives (4 Ratings) - Benzinga
Bio-Techne downgraded to Neutral from Outperform at Baird - TipRanks
Bio-Techne launches GMP TcBuster for cell therapy development By Investing.com - Investing.com Nigeria
Bio-Techne director Amy Herr sells $122,690 in stock By Investing.com - Investing.com Nigeria
Bio-Techne director Amy Herr sells $122,690 in stock - Investing.com India
Bio-Techne Stock Outlook: Is Wall Street Bullish Or Bearish? - Barchart
Bio-Techne Stock Outlook: Is Wall Street Bullish or Bearish? - Inkl
Bio-Techne's (NASDAQ:TECH) Soft Earnings Don't Show The Whole Picture - Yahoo Finance
Bio-Techne launches GMP TcBuster for cell therapy development - Investing.com India
Bio-Techne Announces Release of GMP TcBuster Non-Viral Genome Engineering System - Yahoo Finance
Mirae Asset Global Investments Co. Ltd. Increases Stock Position in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
Earnings call transcript: Bio-Techne Q4 2024 beats EPS forecast By Investing.com - Investing.com Nigeria
Allspring Global Investments Holdings LLC Has $52.64 Million Stake in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
Q4 Earnings Estimate for Bio-Techne Issued By William Blair - MarketBeat
Earnings call transcript: Bio-Techne Q4 2024 beats EPS forecast - Investing.com
Q4 EPS Estimates for Bio-Techne Decreased by Leerink Partnrs - MarketBeat
Bio-Techne (NASDAQ:TECH) Shares Gap DownHere's What Happened - MarketBeat
Brokerages Set Bio-Techne Co. (NASDAQ:TECH) Price Target at $86.57 - MarketBeat
4,474 Shares in Bio-Techne Co. (NASDAQ:TECH) Bought by Summit Trail Advisors LLC - MarketBeat
Bio-Techne Co. (NASDAQ:TECH) Position Reduced by State of Alaska Department of Revenue - MarketBeat
Stephens Investment Management Group LLC Has $52.92 Million Stock Holdings in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
Bio-Techne Corporation: How Spatial Biology and Molecular Diagnostics Are Changing the Game! - Smartkarma
Ex-Dividend Reminder: Cencora, Bio-Techne and Eli Lilly - Nasdaq
Bio-Techne Corp. stock underperforms Monday when compared to competitors - MSN
Bio-Techne Co. (NASDAQ:TECH) Shares Acquired by Sumitomo Mitsui Trust Group Inc. - MarketBeat
Bio-Techne (NASDAQ:TECH) Price Target Raised to $90.00 - MarketBeat
Bio-Techne (NASDAQ:TECH) Releases Quarterly Earnings Results, Misses Estimates By $0.03 EPS - MarketBeat
Bio-Techne (NASDAQ:TECH) Shares Gap Up After Dividend Announcement - MarketBeat
TECH Gears Up to Report Q2 Earnings: Here's What to Expect - MSN
KeyCorp Issues Positive Forecast for Bio-Techne (NASDAQ:TECH) Stock Price - MarketBeat
Bio-Techne (NASDAQ:TECH) Given New $80.00 Price Target at Royal Bank of Canada - MarketBeat
Beyond the Balance Sheet: What SWOT Reveals About Bio-Techne Cor - GuruFocus.com
Trust Point Inc. Buys 7,333 Shares of Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
Bio-Techne Corp. stock underperforms Friday when compared to competitors - MarketWatch
Bio-Techne Appoints Dr. Amy E. Herr as Independent Director and Announces DividendOn January 30, 2025, Bio-Techne Corporation (NASDAQ: TECH) took steps to enhance its Board of Directors with the appointment of Dr. Amy E. Herr as an independent di - Defense World
Conestoga Capital Advisors LLC Buys 5,025 Shares of Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
Bio-Techne Corp (TECH) reports earnings - Quartz
BIO-TECHNE Corp SEC 10-Q Report - TradingView
3 Genomics Stocks Unlocking the Future of Medicine - Inkl
There is no doubt that Bio-Techne Corp (TECH) ticks all the boxes. - SETE News
Bio-Techne Corporation (NASDAQ:TECH) Q2 2025 Earnings Call Transcript - Insider Monkey
Bio-Techne beats Q2 earnings estimates on improving demand for biotech products - ETHealthWorld
Bio-Techne Corp (TECH) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Expansion - GuruFocus.com
Bio-Techne Corp (TECH) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
Bio Techne Corp (TECH) 財務データ
収益
当期純利益
現金流量
EPS
Bio Techne Corp (TECH) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Herr Amy E. | Director |
Feb 14 '25 |
Sale |
65.96 |
1,860 |
122,691 |
1,976 |
0.27%
3.05%
大文字化:
|
ボリューム (24 時間):